Clinical and Ultrasound Score for Evaluation of Previous Cesarean Section Scar (NCT04856254) | Clinical Trial Compass
CompletedNot Applicable
Clinical and Ultrasound Score for Evaluation of Previous Cesarean Section Scar
Egypt150 participantsStarted 2020-08-01
Plain-language summary
Cesarean delivery rates have increased dramatically worldwide. In the United States, cesarean section (CS) rates increased from 5% of all deliveries in 1970 to a high of 31.9% in 2016.Although efforts were made to reduce the number of CS, it failed to achieve the 15% rate recommended by the World Health Organization (WHO).Repeat CS is the most significant factor contributing to overall increased CS rates. The primary indication of repeat CS is a prior CS. The trial of labor after cesarean (TOLAC) is an attempt to reduce CS rates. Several national medical associations have provided practice guidelines for vaginal birth after cesarean section (VBAC), but these differ across countries.VBAC is relatively safe when compared with repeat CS.However, TOLAC rates have dropped significantly worldwide in recent years.
Who can participate
Age range
17 Years – 40 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Previous one cesarean section for non permenant indication.
* Pregnant women without any medical disorders.
* Gestational age: 36-40 weeks.
* Pregnant woman with singleton pregnancy.
* Clinically adequate pelvis.
* Normal ultrasonographic findings (gestational age, fetal structures and placental site).
* Cephalic vertex presentation.
* Patients not inlabour.
Exclusion Criteria:
* Previous repair of ruptured uterus.
* Women with history of long-term treatment for infertility.
* Multiple pregnancies.
* Previous operations in uterus rather than cesarean section.
* Polyhydramnios and Fetal macrosomia.
* Women with bad obstetric history (previous IUFD or difficult delivery).
* Disturbance of fetal heart rate (determined with the CTG).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Novel score (Mosbah) score for evaluation of previous cesarean section scar